Healthy Extracts Inc (HYEX)

[mzasif]

They NEVER provided a firm merger date...Oct 10th, 13th or any other dates were just tentative.

from https://eqova.com/eqova-acquisition/
The acquisition is expected to close on October 13th, but could take longer. The signed LOI by the two entities extends till the end of October.

from http://www.greycloaktech.com/2017/10/grey-cloaks-acquisition-target-eqova-exhibits-denvers-integrative-medicine-summit/

On September 19, 2017, the Company announced the signing of a Letter of Intent to acquire Eqova Life Sciences. Eqova Life Sciences, located in Denver, Colorado, develops clinical grade Full Spectrum Hemp Oil products, sold exclusively via partnerships with licensed medical practitioners to use with their patients. The Company anticipates completing the acquisition of Eqova within the next 20 days upon the successful completion of due diligence and final acquisition agreements.[/I]

from http://www.greycloaktech.com/2017/09/grey-cloak-tech-announces-letter-intent-acquire-eqova-life-sciences/

Prior to signing the Letter of Intent, the companies held numerous meetings to assess alignment of corporate culture. The Letter of Intent includes obligations and conditions to the closing that are typical in similar transactions, including satisfactory due diligence and all required organizational action, and the ability of Eqova to deliver audited financial statements as required by Regulation S-X of the Securities Exchange Act. The parties expect to consummate the transaction as soon as reasonably practicable.

from https://emerginggrowth.com/greycloak-otc-pink-grck-flies-high-new-hempoil-acquisition-target-eqova-life-sciences/

The market reaction to the acquisition of Eqova Life Sciences was very favorable trading up 132% on Friday. The size of the Cannabinoid (CBD) products market is expected to reach $2.1 Billion by 2020 according to the Hemp Business Journal. This means there is still a lot of opportunity for innovative startups like Eqova. When companies enter a market that is growing so large and so fast, entrepreneurs can lose sight of their focus. The pending acquisition of Eqova Life Sciences by Grey Cloak Technology (GRCK) due to close on October 10th seems like an ideal union that will provide capital markets liquidity to a startup company focused on the medical practitioner market.

from http://financeregistrar.com/grey-cloak-tech-inc-otcmktsgrck-pops-higher-speculation-transition/

As noted above, GRCK is starting to get some attention as a pivot into the cannabis patch on an M&A deal set to close on 10/10/17

William Bossung, CFO of Grey Cloak Tech said, “For several months, we have been looking at the cannabis industry for an acquisition. While we have a good core product in our Fraudlytic™, the click fraud prevention industry has become very crowded and competitive. Therefore, we have been examining the many opportunities available in the cannabis industry. We have been looking for a way to grow shareholder value by adding acquisitions from a rapidly growing industry such as CBD.”

However, we would also note a Schedule 13G filed on Friday that states that Oakmore Opportunity Fund I LP, has just purchased 4,657,247 shares of GRCK stock. We suspect this was the actual most proximal catalyst for the pop on Friday. We aren’t sure of the implications of this move, but it does suggest one thing loud and clear: there is a demand for shares of the stock.